HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $29.10-$31.50 vs $30.14 Est; Affirms FY2026 Sales Guidance of $76.500B-$80.000B vs $78.676B Est

HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $29.10-$31.50 to $29.10-$31.50 vs $30.14 analyst estimate. Affirms FY2026 sales outlook from $76.500 billion-$80.000 billion to $76.500 billion-$80.000 billion vs $78.676 billion estimate.